Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04120363 · ClinicalTrials.gov registry record · Phase 4
Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations
A Phase 4 study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 34
- Enrollment target
NCT04120363 is a Phase 4 study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 34 participants.
The verdict
NCT04120363, a Phase 4 study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 34 participants
- Enrollment target
Study Summary
The objective of this study is to determine the effects of a single dose of testosterone undecanoate during and in recovery from simulated operational stress.
Interventions
- DRUG Testosterone Undecanoate
- DRUG Sesame Oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2019-09-23 |
| Est. Completion | 2021-07-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04120363
The ClinicalTrials.gov registry entry for NCT04120363 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Testosterone Undecanoate is the first listed.
NCT04120363 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04120363 about?
NCT04120363 is a clinical study titled "Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations". The objective of this study is to determine the effects of a single dose of testosterone undecanoate during and in recovery from simulated operational stress.
What is the current status of trial NCT04120363?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 34 participants. The study started on 2019-09-23. Estimated completion is 2021-07-08.
What interventions are being tested in trial NCT04120363?
The interventions under investigation include: Testosterone Undecanoate (DRUG), Sesame Oil (DRUG).
Who is sponsoring clinical trial NCT04120363?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.